Skip to content

Trimas TRS Remainder of Fiscal Year 2024

Remainder of Fiscal Year 2024 at other companies

AptarGroup logo
AptarGroupATR
Sonoco Products logo
Sonoco ProductsSON
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Chart Industries logo
Chart IndustriesGTLS

Other financials

Income statement

See full
Revenue$168.3M+10.4%
Gross profit$36.9M+12.3%
Operating income$6.9M-3.6%
Net income$800.8M+6,348%
EPS (diluted)$21.40+7,033%

Balance sheet

See full
Cash & equivalents$1.3B+3,904%
Total debt$439.9M-9.2%
Total equity$1.4B+111%
Total assets$2.3B+64.8%

Cash flow

See full
Operating cash flow-$19.4M-311%
CapEx$5.2M-59.7%
Free cash flow-$24.6M-556%

Valuation

See full
Market cap$1.56B+41.9%
Enterprise value$692.33M-65.6%
P/E1.7×-33.2×
P/S2.4×+0.6×

Profitability

See full
Gross margin-0.1%-2.1pp
Operating margin8%-1.0pp
Net margin137.3%+132pp
FCF margin7.3%+3.1pp

Returns & leverage

See full
Return on equity85.1%+80.4pp
Debt / equity0.3×-0.4×
Current ratio4.9×+2.0×

Where this comes from

Reported directly by Trimas in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear.

The official record: Trimas’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trimas's remainder of fiscal year 2024.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trimas's remainder of fiscal year 2024?
Trimas (TRS) reported remainder of fiscal year 2024 of $6.57M in Q1 2026.
How has Trimas's remainder of fiscal year 2024 changed year-over-year?
Trimas's remainder of fiscal year 2024 decreased by 15.3% year-over-year, from $7.76M to $6.57M.